Skip to main content
OpenTrials

Clinical trial condition

Hyperlipoproteinemia Type II

Explore clinical trials studying Hyperlipoproteinemia Type II. Study availability and eligibility vary by location and protocol.

176 public trials 31 recruiting studies
Refine in advanced search Browse all conditions

Hyperlipoproteinemia Type II trial results

Enrolling by invitation

Long-term Efficacy and Safety of OLE LIB003 in HoFH, HeFH, and High-risk CVD Patients Requiring Further LDL-C Reduction

NCT04798430

Conditions
Cardiovascular Disease With Mention of Arteriosclerosis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, +12 more
Locations
  • NorthShore University Health System Evanston, Illinois, United States
  • Sterling Research Group Cincinnati, Ohio, United States
  • The Lindner Research Center Cincinnati, Ohio, United States
  • Metabolic & Atherosclerosis Research Center (MARC) Cincinnati, Ohio, United States
View Trial Details
Active, not recruiting

Specified Drug-use Survey of Leqvio for s.c. Injection.

NCT06275724

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Hypercholesterolaemia, +12 more
Locations
  • Novartis Investigative Site Handa, Aichi-ken, Japan
  • Novartis Investigative Site Ichinomiya, Aichi-ken, Japan
  • Novartis Investigative Site Ichinomiya, Aichi-ken, Japan
  • Novartis Investigative Site Komaki, Aichi-ken, Japan
View all 107 locations
View Trial Details
Active, not recruiting

An Adapted Brazilian Cardioprotective Diet, Phytosterols and Krill Oil in Familial Hypercholesterolemia (DICA-FH)

NCT06331195

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Hypercholesterolemia, +9 more
Locations
  • Hcor São Paulo, Brazil
  • OCARA Belém, Brazil
  • Centro Oncológico de Roraima Boa Vista, Brazil
  • Instituto de Cardiologia e Transplantes do DF Brasília, Brazil
View all 24 locations
View Trial Details

Related conditions